‘It’s a great place to work,’ he says.
Improving pharmaceutical facility design with Chips, generative design and automation.We are now using chips as the basis of generative designs to allow us to automate the design process.
In this context, generative design means using computers to assemble designs based on a set of rules, components and input parameters.We generate very large numbers of options for a particular design requirement, and then get humans back in to look at those critically.. We can generate many more options using automation.Sometimes we find something which human expertise has not spotted.
Generative design can create unexpected options with high value.. We are now working on making Chips available to very large numbers of users through a web interface, to use generative design for pharmaceutical plants.We are also associating process simulation data with those Chips, so that we can look at throughput, and use throughput to define what Chips we need..
The Chip as future enabler.
We are often asked what ‘Chip’ stands for.Innovation doesn’t respect discipline or sector boundaries.
It needs to sit across the entire operation.We are interested in increasing quality, productivity, timeliness and cost effectiveness.
So we have to ask certain key questions from the outset, like: what’s the least amount of material that could possibly be used to build an asset?What’s the smallest number of times that asset could be touched or processed by people?